| | Per Share and Accompanying Common Warrant | | | Per Pre- Funded Common Warrant and Accompanying Warrant | | | Total | |
Public offering price | | | $ | | | $ | | | $ |
Underwriting discounts and commissions(1) | | | $ | | | $ | | | $ |
Proceeds to Elicio Therapeutics, Inc. before expenses | | | $ | | | $ | | | $ |
(1) | We have agreed to reimburse the underwriters for certain expenses. See “Underwriting.” |